Real Difference Between Clear and Correct English

Many professionals still believe that correct English is the goal.

Grammatically accurate. Well structured. Carefully checked.

And yet their messages still slow decisions down, trigger endless follow-ups, or quietly undermine their credibility.

Because correctness and clarity are not the same thing.

Correct English focuses on rules.

Clear English focuses on outcomes.

Correct English asks:

Is this sentence grammatically sound?

Clear English asks:

Can the other person immediately understand what matters, what changes, and what happens next?

In pharma, this difference is not academic. It is operational.

A message can be 100 percent correct and still be dangerous.

Dangerous because it hides responsibility.

Dangerous because it dilutes risk.

Dangerous because it forces the reader to interpret instead of decide.

Clear English removes interpretation.

Correct English often sounds like this:

“The issue was identified and corrective actions are being considered.”

Clear English sounds like this:

“We identified the issue yesterday. The team is proposing two corrective actions. A decision is needed by Friday.”

Both are correct.

Five Practical Ways to Ensure Your Point Is Remembered in Pharma

The Biggest Risk to Influence in Pharma Is Not Weak Data or Difficult Stakeholders

It Is Allowing the Key Message to Disappear in the Noise

Pharma professionals—from clinical research and regulatory affairs to QA, PV, medical affairs, and commercial—face a common challenge. We deal with complex details, technical language, and audiences who are often busy or skeptical. If we don’t highlight the central point, it gets buried. Once it is buried, so is our impact.

That’s why we need practical language techniques. These techniques ensure our most important ideas are heard, remembered, and acted upon.

1. The Spotlight Move (Cleft Sentences)

Cleft sentences restructure information so that the key part stands out.

Instead of saying:

“The clinical team achieved enrollment targets.”

We can say:

“It was the clinical team that achieved enrollment targets.”

This version places the achievement squarely on the team, ensuring recognition is clear.

Here are more examples:

• Regulatory: “It was the updated submission strategy that secured approval.”

• QA: “It was the audit preparation that prevented findings.”

• PV: “What matters most at this stage is rapid case processing.”

  
  

This tool works well in boardroom discussions, audit defenses, and performance updates. It signals to the audience exactly where to direct their attention.

2. The Authority Flip (Inversion)

Inversion alters the usual word order to add strength and authority.

Talking About the Future in Pharma

Let’s talk about the future.

Not the futuristic, AI-will-run-the-world kind—but the real, everyday future that pharma professionals deal with constantly. Whether you're reviewing timelines, preparing for inspections, planning site visits, following up on safety reports, or getting ready for the next big product launch—you're always communicating what will happen next.

And here’s the catch: English doesn’t just have one future tense. It has a whole set of tools—will, going to, present continuous, present simple, shall, future continuous, future perfect, and future perfect continuous. Each one sends a slightly different message.

Let’s break it down with examples that fit across pharma roles.

🛠 Will = Instant decisions or offers

"I’ll double-check the SOP now."

You just decided this. No prior plan. Maybe your colleague just flagged an inconsistency and you said this in the moment. Quick, helpful, responsive.

🗓 Going to = Planned actions

"I’m going to run a compliance check this week."

You already planned it. Maybe it’s on your calendar. You’ve prepared, and now you’re letting others know.